Health Care Utilization and Direct Medical Costs of Tennis Elbow: A Population-Based Study
- PMID: 27215568
- PMCID: PMC4922520
- DOI: 10.1177/1941738116650389
Health Care Utilization and Direct Medical Costs of Tennis Elbow: A Population-Based Study
Abstract
Background: Tennis elbow is commonly encountered by physicians, yet little is known about the cost of treating this condition.
Hypothesis: The largest cost associated with treating tennis elbow is procedural intervention.
Study design: Descriptive epidemiology study.
Level of evidence: Level 4.
Methods: This retrospective population-based study reviewed patients who were treated for new-onset tennis elbow between January 1, 2003 and December 31, 2012. All patients were followed up through their medical and administrative records to identify health care encounters and interventions for tennis elbow. Unit costs for each health service/procedure were adjusted to nationally representative unit costs in 2013 inflation-adjusted dollars.
Results: In a cohort of 931 patients who had 2 or more clinical encounters for new-onset lateral epicondylosis during a 12-month period after initial diagnosis, 62% received a median of 3 physical therapy sessions (cost, $100/session) and 40% received a median of 1 steroid injection (cost, $82/injection). Only 4% of patients received surgical intervention with mean costs of $4000. The mean (median) total direct medical cost of services related to lateral epicondylosis for the entire cohort was $660 ($402) per patient over the 1-year period after diagnosis. Patients who continued to be treated conservatively between 6 and 12 months after diagnosis incurred relatively low median costs of $168 per patient.
Conclusion: In this cohort, a second encounter with a physician for tennis elbow was a strong predictor of increased treatment cost due to a higher likelihood of specialist referral, use of physical therapy, or treatment with steroid injection.
Clinical relevance: The majority of direct medical spending on tennis elbow occurs within the first 6 months of treatment, and relatively little expense occurs between 6 and 12 months after diagnosis unless a patient undergoes surgical intervention.
Keywords: cost; lateral elbow tendinosis; lateral epicondylitis; tennis elbow.
© 2016 The Author(s).
Conflict of interest statement
The following author declared potential conflicts of interest: Bernard F. Morrey, MD, is a paid consultant for Tenex Health. This study was made possible by the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under award number R01AG034676. The findings and conclusions of this report are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Figures
Similar articles
-
Economic evaluation favours physiotherapy but not corticosteroid injection as a first-line intervention for chronic lateral epicondylalgia: evidence from a randomised clinical trial.Br J Sports Med. 2016 Nov;50(22):1400-1405. doi: 10.1136/bjsports-2015-094729. Epub 2015 Jun 2. Br J Sports Med. 2016. PMID: 26036675 Clinical Trial.
-
Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care.Pharmacoeconomics. 2004;22(3):185-95. doi: 10.2165/00019053-200422030-00004. Pharmacoeconomics. 2004. PMID: 14871165 Clinical Trial.
-
The epidemiology and health care burden of tennis elbow: a population-based study.Am J Sports Med. 2015 May;43(5):1066-71. doi: 10.1177/0363546514568087. Epub 2015 Feb 5. Am J Sports Med. 2015. PMID: 25656546 Free PMC article.
-
Management of lateral epicondylitis.Orthop Traumatol Surg Res. 2019 Dec;105(8S):S241-S246. doi: 10.1016/j.otsr.2019.09.004. Epub 2019 Sep 19. Orthop Traumatol Surg Res. 2019. PMID: 31543413
-
Lateral tennis elbow: "Is there any science out there?".J Shoulder Elbow Surg. 1999 Sep-Oct;8(5):481-91. doi: 10.1016/s1058-2746(99)90081-2. J Shoulder Elbow Surg. 1999. PMID: 10543604 Review.
Cited by
-
Prevalence of lateral epicondylosis in veteran manual wheelchair users participating in adaptive sports.J Spinal Cord Med. 2022 Mar;45(2):238-244. doi: 10.1080/10790268.2020.1771243. Epub 2020 Jun 12. J Spinal Cord Med. 2022. PMID: 32527209 Free PMC article.
-
Efficacy of Ultrasonic Tenotomy and Debridement and Platelet-Rich Plasma Injections for Lateral Elbow Tendinopathy.J Hand Surg Glob Online. 2023 May 18;5(5):667-672. doi: 10.1016/j.jhsg.2023.04.004. eCollection 2023 Sep. J Hand Surg Glob Online. 2023. PMID: 37790822 Free PMC article.
-
Trends in Corticosteroid Injections for Treatment of Lateral Epicondylitis: An Analysis of 80,169 Patients.J Am Acad Orthop Surg Glob Res Rev. 2021 Sep 10;5(9):e21.00186. doi: 10.5435/JAAOSGlobal-D-21-00186. J Am Acad Orthop Surg Glob Res Rev. 2021. PMID: 34506365 Free PMC article.
-
Arthroscopic release and decortication provide earlier return to work with similar patient satisfaction compared to continued intensive conservative therapy for recalcitrant tennis elbow: a retrospective observational study.Eur J Orthop Surg Traumatol. 2024 Jan;34(1):175-180. doi: 10.1007/s00590-023-03628-5. Epub 2023 Jun 30. Eur J Orthop Surg Traumatol. 2024. PMID: 37389708
-
Epidemiology of lateral and medial epicondylitis in South Korea: A nationwide population-based study.Medicine (Baltimore). 2025 Feb 28;104(9):e41588. doi: 10.1097/MD.0000000000041588. Medicine (Baltimore). 2025. PMID: 40020113 Free PMC article.
References
-
- Korthals-de Bos I, Smidt N, van Tulder M, et al. Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary care. Pharmacoeconomics. 2004;22:185-195. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials